Western Blot (1:1000) Immunohistochemistry (1:10-50) The optimal working dilution should be determined by the end user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Buffer
In PBS (0.09 % sodium azide)
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing.
Wang, Hewitt, Liu, Zhou, Zhu, Zhou, Zhang, Quan, Bai, Xu: "Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumours." in: British journal of cancer, Vol. 94, Issue 5, pp. 686-91, (2006) (PubMed).
Hagen, Cross, Culbert, West, Frame, Morrice, Reith: "FRAT1, a substrate-specific regulator of glycogen synthase kinase-3 activity, is a cellular substrate of protein kinase A." in: The Journal of biological chemistry, Vol. 281, Issue 46, pp. 35021-9, (2006) (PubMed).
Hino, Michiue, Asashima, Kikuchi: "Casein kinase I epsilon enhances the binding of Dvl-1 to Frat-1 and is essential for Wnt-3a-induced accumulation of beta-catenin." in: The Journal of biological chemistry, Vol. 278, Issue 16, pp. 14066-73, (2003) (PubMed).
Target
FRAT1
(Frequently Rearranged in Advanced T-Cell Lymphomas (FRAT1))